Stempoint Capital’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-136,139
| Closed | -$2.2M | – | 71 |
|
|
2025
Q1 | $2.2M | Buy |
+136,139
| New | +$2.2M | 0.7% | 35 |
|
|
2024
Q3 | – | Sell |
-150,450
| Closed | -$3.54M | – | 63 |
|
|
2024
Q2 | $3.54M | Buy |
150,450
+88,197
| +142% | +$2.07M | 1.04% | 31 |
|
|
2024
Q1 | $2.36M | Sell |
62,253
-316,513
| -84% | -$12M | 0.62% | 35 |
|
|
2023
Q4 | $8.15M | Buy |
+378,766
| New | +$8.15M | 2.17% | 18 |
|